新型胺衍生物作为有前途的抗菌菌剂
Martin Kufa1, Vladimir Finger1, Ondrej Kovar1
1Faculty of Pharmacy in Hradec Kralové, Charles University, Akademika Heyrovskeho 1203, 500 03, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
European journal of medicinal chemistry
|December 24, 2025
概括
研究人员开发了新的皮里米丁衍生物来对抗结核病 (TB). 化合物55a对抗耐药性Mycobacterium结核病菌株具有很高的疗效,并且具有有前途的代谢稳定性,提供了一种新的治疗途径.
科学领域:
- 药用化学 医学化学
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
背景情况:
- 结核病 (TB) 是一个重要的全球卫生问题,由耐药性Mycobacterium tuberculosis (Mtb) 菌株加剧.
- 非结核菌 (NTM) 也会导致人类和动物的机会性感染.
研究的目的:
- 设计,合成和评估新型胺衍生物作为潜在的抗菌菌剂.
- 为了确定具有高效的化合物对药物敏感和耐药的Mtb和代表性的NTM菌株.
主要方法:
- 系统性结构-活性关系 (SAR) 研究对合成的胺基因衍生物进行了研究.
- 使用最小抑制度 (MIC99) 试验评估了抗菌菌活性.
- 使用人类肝脏显微体评估了代谢稳定性.
主要成果:
- 衍生品55a对药物敏感的Mtb表现出强烈的抗菌活性 (MIC99 = 8μM),并保留了对多药耐药和广泛耐药菌株的有效性.
- 化合物55a表现出良好的代谢稳定性 (187分半衰期,7.41μL/分钟/毫克蛋白质内在清除).
- 几种化合物显示出对Mycobacterium kansasii (NTM) 的有希望的活动,以及对其他细菌菌株的mycobacteria的选择性.
结论:
- 胺衍生物55a是一种非常有前途的化合物,用于开发新型抗结核病疗法.
- 这些已识别的化合物代表了对抗菌根菌感染进一步优化的有价值的结构动机.
相关概念视频
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.6K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...
3.6K
Basicity of Heterocyclic Aromatic Amines
6.8K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.8K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K


